Swiss biotech Alentis Therapeutics has secured $181.4 million, money that will be used to launch clinical trials for two ...

Today, Novo Nordisk A/S has entered into an agreement to purchase 6,311,250 B shares of DKK 0.10 at a value of DKK ...

Pharmaceutical stocks declined as President-elect Donald Trump said he’s tapping Robert F. Kennedy Jr. to run the Department ...

Kepler Capital analyst David Evans maintained a Hold rating on Novo Nordisk (0QIU – Research Report) on November 6 and set a price target of DKK715.00. The company’s shares closed last ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Disruptive analytics’ Substack by Magnus Ofstad. In this article ...

Novo Nordisk (NVO) has released an update. Novo Nordisk has announced a significant transaction under its 2024 share repurchase program, ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

The Shelton Capital International Select Fund returned 7.91%, underperforming the MSCI AC World ex-US index by 0.15%, with ...

As part of this, Novo Nordisk A/S has now initiated a new share repurchase ... The purpose of the programme is to reduce the ...

Fidelity Diversified International Fund is a broadly diversified international equity strategy that seeks capital growth by ...

The Arkansas Republican, who could be the next chairman of the top banking panel in the House, could find some areas of ...

Modifying Treatment for AADC Deficiency in the United States SOLANA BEACH, CA / / November 13, 2024 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the 'Company'), a global therapy-enabling platform company ...